Factors and Disease‐Specific Outcomes Associated With Treatment Delays in Osteosarcoma: A Population‐Based Retrospective Cohort Study
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.70087 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Kate S Woods und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Creighton University; Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms, Time-to-Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Introduction
Time to initiation of therapy in oncological care is an influential factor in disease progression and survival outcomes in many cancer types. We aim to identify factors associated with delayed time to treatment (TTT) in high‐grade osteosarcoma and its relationship to disease‐specific survival (DSS).
Methods
The SEER database was queried for biopsy‐confirmed cases of high‐grade osteosarcoma between 2000 and 2021 using ICD‐O‐3 histology codes 9180/3–9194/3 and primary site codes C40.0–41.9. χ 2 , Kaplan–Meier with log‐rank testing, and stepwise multivariable logistic regression were completed using SPSS, with significance set to p < 0.05.
Results
Kaplan–Meier analysis demonstrated significantly reduced 5‐ and 10‐year DSS in patients with TTT over 1 month ( p < 0.001). Multivariable analysis identified advanced age groups and tumors of the cranium (aOR 2.48; 95% CI 1.96–3.13), thorax (aOR 1.72; 95% CI 1.13–2.61), and pelvis (aOR 1.71; 95% CI 1.31–2.23) as factors associated with TTT delays over 1 month. Black race and Hispanic ethnicity were also significantly associated with treatment delays in subset analysis of patients < 40 years (aOR 1.74; 95% CI 1.27–2.39 and aOR 1.31; 95% CI 1.01–1.70).
Conclusion
These findings reveal disparities in TTT for osteosarcoma patients based on age, race/ethnicity, and tumor location, highlighting the need for equitable access to early care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Creighton University; Omaha, Nebraska, USA.
- Department of Internal Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois, USA.
- Department of Orthopaedic Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Internal Medicine, Division of Hematology and Oncology, CHI Creighton University Medical Center, Omaha, Nebraska, USA.
ORCID-Profile: Kate S Woods
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Woods, K. S., Kauper, R. T., Kohli, A., Taylor, M. A., Gavia, A., & Silberstein, P. (2025). Factors and Disease‐Specific Outcomes Associated With Treatment Delays in Osteosarcoma: A Population‐Based Retrospective Cohort Study. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70087
Vancouver
Woods KS, Kauper RT, Kohli A, Taylor MA, Gavia A, Silberstein P. Factors and Disease‐Specific Outcomes Associated With Treatment Delays in Osteosarcoma: A Population‐Based Retrospective Cohort Study. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70087
BibTeX
@article{Woods2025,
author = {Woods, Kate S and Kauper, Ryan T and Kohli, Anisha and Taylor, Mitchell A and Gavia, Alex and Silberstein, Peter},
title = {Factors and Disease‐Specific Outcomes Associated With Treatment Delays in Osteosarcoma: A Population‐Based Retrospective Cohort Study},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.70087}
}
EUVIMED